← SynDRA
MAVATREP
SynDRA canonical compound SYN0037183 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | TRPV1 |
| Mechanism of action | transient receptor potential channel antagonist |
All known targets
Mechanisms of action (all sources)
- TRPV1 ANTAGONIST
- Vanilloid receptor antagonist
- transient receptor potential channel antagonist
Cross-references
Synonyms
- JNJ-39439335
- JNJ 39439335
- UNII-F197218T99
- F197218T99
- Mavatrep [USAN:INN]
- Mavatrep (USAN)
- SCHEMBL1796599
- SCHEMBL1797450
- CHEMBL2364618
- Mavatrep(JNJ-39439335)
- DTXSID90241905
- BCP23936
- EX-A2266
- ZINC43175494
- BDBM50086717
- AKOS030527038
- DB12875
- CS-4591
- SB17026
- trans-2-(2-(2-(2-(4-Trifluoromethylphenyl)vinyl)-1H-benzimidazol-5-yl)phenyl)propan-2-ol
- BC600772
- HY-16935
- B5930
- J3.561.747G
- D10370
- mavatrepum
- RefChem:925371
- DTXCID80164396
- Mavatrep [USAN]
- MAVATREP [INN]
- MAVATREP [MI]
- MAVATREP [WHO-DD]
- orb1308061
- SCHEMBL29636978
- C25H21F3N2O
- GTPL12755
- Mavatrep; JNJ-39439335
- ORDHXXHTBUZRCN-NTEUORMPSA-N
- GLXC-90339
Look up MAVATREP in the interactive SynDRA portal →